Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

PEG3350 vs Senna After Urogyn Surgery

St. Joseph's Health, New York · NCT06825260

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
254
US sites recruiting
1
Study start
April 23, 2025
Record last updated
May 28, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this study is to evaluate whether polyethylene glycol 3350 (PEG3350) versus senna is better at relieving postoperative constipation after urogynecologic surgery. The main questions it aims to answer are:

What number of patients taking PEG3350 have obstructed defecation syndrome (ODS), a form of constipation, vs those taking senna in the week after urogynecologic surgery? What patient-level and procedure-level characteristics are associated with postoperative ODS, in patients taking PEG3350 vs senna? participants will: Take their randomized medication daily for seven days after surgery Fill out an ODS questionnaire before and one week after surgery Complete a daily bowel diary for 7 days after surgery

Being studied: Senna; Polyethylene glycol 3350

Conditions: Obstructive Defecation Syndrome; Postoperative Constipation

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Inclusion criteria includes women scheduled for urogynecologic surgery for pelvic organ prolapse and/or stress urinary incontinence and at least 18 years old.

Exclusion Criteria

  • Exclusion criteria include undergoing concomitant bowel surgery (colonic resection, anal sphincter repair, rectovaginal fistula repair, rectopexy) or placement of a sacral neuromodulation device alone.

Recruiting US locations

  • St. Joseph's Health Hospital

    Syracuse, NY 13203

    Site contact: Keila S Muniz, MD · 631-896-7937 · keila.muniz@sjhsyr.org

Study contacts (from the official record)

  • Keila S Muniz, MD · 631-896-7937 · keila.muniz@sjhsyr.org
All healthy volunteers studies in New York →
PEG3350 vs Senna After Urogyn Surgery (NCT06825260) | Bored Studies